ALS Biopharma (United States)

Recent papers from ALS Biopharma (United States)

1. Structural basis for sirtuin 2 activity and modulation: Current state and opportunitiesJournal of Biological Chemistry · 2025
2. Proceedings of the second annual dengue endgame summit: A call to actionPLoS neglected tropical diseases · 2025
3. An allosteric inhibitor of sirtuin 2 deacetylase activity exhibits broad-spectrum antiviral activityJournal of Clinical Investigation · 2023
4. Nano-hydroxyapatite Before the Science CourtNanoEthics · 2023
5. Dipeptide Prodrugs of the Glutamate Modulator RiluzoleACS Medicinal Chemistry Letters · 2018
6. Considerations of Environmentally Relevant Test Conditions for Improved Evaluation of Ecological Hazards of Engineered NanomaterialsEnvironmental Science & Technology · 2016
7. Fragile X protein mitigates TDP-43 toxicity by remodeling RNA granules and restoring translationHuman Molecular Genetics · 2015
8. Synthesis, Stereochemical Analysis, and Derivatization of Myricanol Provide New Probes That Promote Autophagic Tau ClearanceACS Chemical Biology · 2015
9. Nebulised budesonide using a novel device in patients with oral steroid-dependent asthmaEuropean Respiratory Journal · 2014
10. Development of a Novel Nonradiometric Assay for Nucleic Acid Binding to TDP-43 Suitable for High-Throughput Screening Using AlphaScreen® TechnologySLAS DISCOVERY · 2010
11. Current Nervous System Related Drug Targets for the Treatment of Amyotrophic Lateral SclerosisCurrent Pharmaceutical Design · 2010
12. The role of sulfamide derivatives in medicinal chemistry: a patent review (2006 – 2008)Expert Opinion on Therapeutic Patents · 2009
13. Glyceraldehyde-3-phosphate dehydrogenase as a target for small-molecule disease-modifying therapies in human neurodegenerative disordersJournal of Psychiatry and Neuroscience · 2004
14. Enhancement of Intestinal Model Compound Transport by DS-1, a Modified Quillaja SaponinJournal of Pharmaceutical Sciences · 1998